Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.

Sibylle WinterhalterAnnabelle EckertGerrit-Alexander Vom BrockeAlice SchneiderDominika PohlmannDaniel PilgerAntonia M JoussenMatus RehakUlrike Grittner

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2017)

In a clinical setting, comparable improvement in BCVA and CRT were observed after DEX and IVR injections for treatment of BRVO. CRVO patients showed greater benefit with IVR.

Keyphrases

diabetic retinopathy
newly diagnosed
end stage renal disease
low dose
big data
atrial fibrillation
left ventricular